[1]淦作梅,廖 萌.观察利福平、胰岛素联合治疗肺结核合并糖尿病的疗效及安全性[J].医学信息,2024,37(16):84-87.[doi:10.3969/j.issn.1006-1959.2024.16.018]
　GAN Zuo-mei,Liao Meng.Observation on the Efficacy and Safety of Rifampicin Combined with Insulin in the Treatmentof Pulmonary Tuberculosis Complicated with Diabetes Mellitus[J].Journal of Medical Information,2024,37(16):84-87.[doi:10.3969/j.issn.1006-1959.2024.16.018]
点击复制

观察利福平、胰岛素联合治疗肺结核合并糖尿病的疗效及安全性()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年16期
页码:
84-87
栏目:
论著
出版日期:
2024-08-15

文章信息/Info

Title:
Observation on the Efficacy and Safety of Rifampicin Combined with Insulin in the Treatmentof Pulmonary Tuberculosis Complicated with Diabetes Mellitus
文章编号:
1006-1959（2024）16-0084-04
作者:
淦作梅; 廖 萌
武宁县人民医院感染科，江西 武宁 332300
Author(s):
GAN Zuo-mei; Liao Meng
Department of Infectious Diseases,Wuning County People’s Hospital,Wuning 332300,Jiangxi,China
关键词:
利福平; 胰岛素; 肺结核; 糖尿病; 安全性
Keywords:
Rifampicin; Insulin; Pulmonary tuberculosis; Diabetes mellitus; Security
分类号:
R587.1；R521
DOI:
10.3969/j.issn.1006-1959.2024.16.018
文献标志码:
A
摘要:
目的 观察利福平、胰岛素联合治疗肺结核合并糖尿病的疗效及安全性。方法 选取2020年1月-2023年6月我院接诊的62例肺结核合并糖尿病患者为研究对象，采用随机数字表法分为对照组和观察组，各组31例。对照组予以口服降糖药（二甲双胍、阿卡波糖、达格列净）联合利福平治疗，观察组采用胰岛素注射联合利福平治疗。比较两组临床疗效、血糖指标[空腹血糖（FBG）、糖化血红蛋白（HbA1c）、餐后2 h血糖（2hPBG）]、临床症状（发热、咳嗽、咯血）缓解时间、血糖达标时间及不良反应发生率。结果 观察组治疗总有效率（93.55%）高于对照组（83.87%）（P＜0.05）；两组FBG、HbA1c、2 hPBG均低于治疗前，且观察组低于对照组（P＜0.05）；观察组发热、咳嗽、咯血缓解时间以及血糖达标时间均低于对照组（P＜0.05）；观察组不良反应发生率（6.45%）低于对照组（19.35%）（P＜0.05）。结论 利福平联合胰岛素治疗肺结核合并糖尿病可提高治疗效果，有效改善血糖指标，缩短血糖达标和临床症状缓解时间，且不良反应发生率低，是一种可行、有效的治疗方案。
Abstract:
Objective To observe the efficacy and safety of rifampicin combined with insulin in the treatment of pulmonary tuberculosis complicated with diabetes mellitus.Methods A total of 62 patients with pulmonary tuberculosis complicated with diabetes mellitus who were admitted to our hospital from January 2020 to June 2023 were selected as the research objects. They were divided into control group and observation group by random number table method, with 31 patients in each group. The control group was treated with oral hypoglycemic drugs (metformin, acarbose, dapagliflozin) combined with rifampicin, and the observation group was treated with insulin injection combined with rifampicin. The clinical efficacy, blood glucose indexes [fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), 2 h postprandial blood glucose (2 hPBG)], remission time of clinical symptoms (fever, cough, hemoptysis), time of blood glucose reaching the standard and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group (93.55%) was higher than that in the control group (83.87%) (P<0.05). The levels of FBG, HbA1 c and 2 hPBG in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). The remission time of fever, cough, hemoptysis and the time of blood glucose reaching the standard in the observation group were lower than those in the control group (P<0.05). The incidence of adverse reactions in the observation group (6.45%) was lower than that in the control group (19.35%) (P<0.05).Conclusion Rifampicin combined with insulin in the treatment of pulmonary tuberculosis complicated with diabetes mellitus can improve the therapeutic effect, effectively improve the blood glucose index, shorten the time of blood glucose control and clinical symptom relief, and the incidence of adverse reactions is low. It is a feasible and effective treatment plan.

参考文献/References:

[1]王华,熊延军,孙菁,等.糖尿病合并初治肺结核患者结核分枝杆菌耐药性分析[J].安徽医学,2018,39(5):553-556.[2]李青,贾俊楠,安军,等.二甲双胍对肺结核合并2型糖尿病患者辅助治疗的横断面研究[J].中国热带医学,2018,18(6):609-613.[3]柴改玲.肺结核合并糖尿病患者血糖水平对抗结核治疗的影响[J].河南医学研究,2018,27(6):146-147.[4]王岫峥,董丽娜.胰岛素不同给药方式治疗肺结核合并2型糖尿病的临床观察[J].临床肺科杂志,2017,22(12):2226-2229.[5]吴捍卫,臧颖惠,吕攀.血清糖化血红蛋白、空腹血糖、胰岛素抵抗指数对2型糖尿病合并涂阳肺结核患者强化期治疗后痰菌未转阴的预测价值[J].中国卫生检验杂志,2020,30(5):566-569.[6]信泽涛,姜晨晖,周成立.2型糖尿病合并肺结核患者抗结核治疗同时强化降糖的临床效果[J].中国农村卫生,2018,10(3):54-55.[7]中华医学会糖尿病学分会.中国2型糖尿病防治指南（2020 年版）（上）[J].中国实用内科杂志,2021,41(8):668-695.[8]中华医学会结核病学分会,结核病病理学诊断专家共识编写组.中国结核病病理学诊断专家共识[J].中华结核和呼吸杂志,2017,40(6):419-425.[9]张素娟,韩彦周,王琳,等.2型糖尿病并肺结核患者外周血T淋巴细胞Rho激酶活性变化及其临床意义[J].临床误诊误治,2018,31(11):66-70.[10]王岫峥,韩娜,南艳,等.不同降糖方案对肺结核合并2型糖尿病临床疗效的影响[J].川北医学院学报,2018,33(1):50-52,62.[11]Kumar Nathella P,Babu S.Influence of diabetes mellitus on immunity to human tuberculosis[J].Immunology,2017,152(1):13-24.[12]陈梅英,吴蓓蓓,陈小红,等.多学科联合诊疗模式营养支持在肺结核合并糖尿病患者中的应用[J].实用临床医药杂志,2020,24(1):95-98.[13]邵立群,赵飒.甘精胰岛素联合二甲双胍与胰岛素泵持续皮下输注治疗2型糖尿病合并肺结核的效果比较[J].临床药物治疗杂志,2018,16(6):52-55.[14]曹思哲,郭玉琪．胰岛素、利福平联合胸腺肽α1治疗肺结核合并糖尿病疗效及对患者 CD3+、CD4+、CD8+的影响研究[J].陕西医学杂志,2018,47(9):1178-1184．[15]邢俊蓬.抗结核+强化降糖方法对2型糖尿病伴有肺结核患者的临床治疗效果研究[J].中外医学研究,2019,17(16):4-6.[16]吴捍卫,臧颖惠,吕攀．血清糖化血红蛋白、空腹血糖、胰岛素抵抗指数对2型糖尿病合并涂阳肺结核患者强化期治疗后痰菌未阴转的预测价值[J].中国卫生检验杂志,2020,30(5):566-569．[17]胡丽娜.薄芝糖肽注射液联合2HLZV4HL2V治疗方案对初治菌阳肺结核患者痰菌转阴率及生活质量的影响[J].黑龙江中医药,2019,48(6):189-190.[18]王欣,高瑜,胡萍,等.肺结核合并糖尿病对异烟肼和利福平血药浓度影响的分析[J].贵州医药,2020,44(3):377-379.[19]高见.短期胰岛素强化治疗2型糖尿病合并肺结核的疗效观察[J].现代诊断与治疗,2018,29(9):1462-1463．[20]韩庆,巴清云.血糖水平对肺结核合并糖尿病老年患者临床疗效的影响[J].江苏医药,2018,43(7):517-519.

相似文献/References:

[1]张熠霖,皇晓燕,赵滢滢,等.糖尿病胰岛病变及胰岛β细胞胰岛素分泌损伤检测的整合实验相关经验探讨[J].医学信息,2019,32(01):18.[doi:10.3969/j.issn.1006-1959.2019.01.006]
　ZHANG Yi-lin,HUANG Xiao-yan,ZHAO Ying-ying,et al.Experience in the Integration Experiment of Diabetic Islet Lesions and Islet β-cell Insulin Secretion Damage Detection[J].Journal of Medical Information,2019,32(16):18.[doi:10.3969/j.issn.1006-1959.2019.01.006]
[2]刘 杰.静脉注射利福平治疗老年肺结核的疗效[J].医学信息,2019,32(18):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
　LIU Jie.Efficacy of Intravenous Rifampicin in the Treatment of Senile Pulmonary Tuberculosis[J].Journal of Medical Information,2019,32(16):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
[3]牟 婷,张朝阳.胰岛素联合唑来膦酸治疗糖尿病骨质疏松症对患者血清指标的影响[J].医学信息,2019,32(22):135.[doi:10.3969/j.issn.1006-1959.2019.22.045]
　MU Ting,ZHANG Chao-yang.Effect of Insulin Combined with Zoledronic Acid on Serum Markers in Patients with Diabetic Osteoporosis[J].Journal of Medical Information,2019,32(16):135.[doi:10.3969/j.issn.1006-1959.2019.22.045]
[4]蔡 玲.不同胰岛素给药模式对高龄妊娠期糖尿病患者血糖控制及母婴结局的影响[J].医学信息,2020,33(04):141.[doi:10.3969/j.issn.1006-1959.2020.04.045]
　CAI Ling.Effects of Different Insulin Administration Modes on Blood Glucose Control andMaternal and nfant Outcomes in Elderly Gestational Diabetes Mellitus Patients[J].Journal of Medical Information,2020,33(16):141.[doi:10.3969/j.issn.1006-1959.2020.04.045]
[5]王 伟,刘 英.促胰岛素分泌抗糖尿病药物及其作用机制[J].医学信息,2020,33(11):30.[doi:10.3969/j.issn.1006-1959.2020.11.011]
　WANG Wei,LIU Ying.Insulin-promoting Anti-diabetic Drugs and Its Mechanism of Action[J].Journal of Medical Information,2020,33(16):30.[doi:10.3969/j.issn.1006-1959.2020.11.011]
[6]高艳红,哈海枫,陈小军,等.甘精胰岛素联合瑞格列奈治疗老年2型糖尿病的临床效果[J].医学信息,2021,34(01):152.[doi:10.3969/j.issn.1006-1959.2021.01.041]
　GAO Yan-hong,HA Hai-feng,CHEN Xiao-jun,et al.Clinical Effect of Insulin Glargine Combined with Repaglinide in the Treatment of Elderly Type 2 Diabetes[J].Journal of Medical Information,2021,34(16):152.[doi:10.3969/j.issn.1006-1959.2021.01.041]
[7]李 亚,宋大庆,韩翔宇,等.胰岛素强化降糖治疗对AMI伴高血糖患者心室重构及血清炎性因子影响的Meta分析[J].医学信息,2021,34(07):110.[doi:10.3969/j.issn.1006-1959.2021.07.030]
　LI Ya,SONG Da-qing,HAN Xiang-yu,et al.Meta-analysis of the Effect of Insulin Intensive Hypoglycemic Therapy on Ventricular Remodeling and Serum Inflammatory Factors in Patients with AMI with Hyperglycemia[J].Journal of Medical Information,2021,34(16):110.[doi:10.3969/j.issn.1006-1959.2021.07.030]
[8]陶 蕾,张宏江,范中阳.利拉鲁肽联合胰岛素治疗肥胖2型糖尿病的疗效[J].医学信息,2021,34(23):99.[doi:10.3969/j.issn.1006-1959.2021.23.028]
　TAO Lei,ZHANG Hong-jiang,FAN Zhong-yang.Effect of Liraglutide Combined with Insulin in the Treatment of Obesity Type 2 Diabetes Mellitus[J].Journal of Medical Information,2021,34(16):99.[doi:10.3969/j.issn.1006-1959.2021.23.028]
[9]张 翠,王 喆,杨悦杰,等.利福平联合多西环素及左氧氟沙星治疗布氏菌病的疗效[J].医学信息,2022,35(03):112.[doi:10.3969/j.issn.1006-1959.2022.03.027]
　ZHANG Cui,WANG Zhe,YANG Yue-jie,et al.Effect of Rifampicin Combined with Doxycycline and Levofloxacin in the Treatment of Brucellosis[J].Journal of Medical Information,2022,35(16):112.[doi:10.3969/j.issn.1006-1959.2022.03.027]
[10]张 彤.利拉鲁肽联合胰岛素治疗新诊断肥胖2型糖尿病的临床疗效及安全性[J].医学信息,2022,35(05):159.[doi:10.3969/j.issn.1006-1959.2022.05.042]
　ZHANG Tong.Clinical Efficacy and Safety of Liraglutide Combined with Insulin in the Treatment of Newly Diagnosed Obese Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(16):159.[doi:10.3969/j.issn.1006-1959.2022.05.042]

更新日期/Last Update: 1900-01-01